Term
5 things of ideal anesthetic |
|
Definition
1. Quick induction/emergence
2. Good analgesia
3. Muscle relaxation
4. Ability to make quick changes
5. No S/E
*None of them meet this |
|
|
Term
4 stages of anesthesia (general) |
|
Definition
1. Preanesthetic: calm pre-surgery
2. Induction: Inhalation or IV
3. Maintenance: Opioids, ketamine, BZD
4. Reversal |
|
|
Term
Target anesthetic related to MAC |
|
Definition
|
|
Term
Nitrous Oxide
1. MAC
2. Use
3. ADEs (2) |
|
Definition
1. 105%
2. Induce euphoria
3. Hypoxia, risk of abuse (never use > 70%) |
|
|
Term
Halothane
1. Why does it have slow onset and termination?
2. ADEs (2) |
|
Definition
1. High tissue solubility
2. Arrhythmia; Hepatotoxicity |
|
|
Term
Isoflurane
1. ADE (1)
2. Good things about it (3) |
|
Definition
1. Airway irritant
2. Maintains cardiac funciton; less respiratory depression; smooth emergence |
|
|
Term
Desflurane
1. Fast what?
2. Use
3. ADE (1) |
|
Definition
1. Onset and termination
2. Maintain anesthesia
3. Airway irritant |
|
|
Term
Sevoflurane
1. Use
2. Good (3)
3. Bad (1) |
|
Definition
1. Induction
2. Less pungent (dec laryngospasm); fewer hemodynamic effects; rapid emergence
3. Produces free fluoride so avoid in kids |
|
|
Term
|
Definition
1. Barbiturates: potent and rapid, but respiratory issues
2. Propofol
3. Ketamine
4. Opioids
5. BZDs
6. NMBs |
|
|
Term
Local Anesthetics
1. ____ block tranmission of nerve impulses
2. ___ effect on consciousness |
|
Definition
|
|
Term
Ester vs Amide Classification
1. Bupivacaine
2. Lidocaine
3. Tetracaine |
|
Definition
1. Amide
2. Amide
3. Ester |
|
|
Term
4 most likely causes of allergy |
|
Definition
1. Lidocaine
2. Mepivacaine
3. Prilocaine
4. Sulfites w/ epinephrine |
|
|
Term
2 rapid onset long duration locals |
|
Definition
1. Tetracaine
2. Bupivacaine |
|
|
Term
2 slower onset shorter duration locals |
|
Definition
|
|
Term
Vasopressors with locals
1. Help what with duration
2. Prevents systemic what
3. Helps provide more |
|
Definition
1. Increase
2. Toxicity
3. Hemostasis |
|
|
Term
|
Definition
1. Ischemic necrosis
2. Neurotoxicity
3. Cardiac toxicity
4. Methemoglobenimia (Tx is methylene blue) |
|
|
Term
Best thing to Tx local anesthetic toxicity |
|
Definition
|
|
Term
Max Safe Dose (mg/kg)
1. Bupivicaine
2. Lidocaine |
|
Definition
|
|
Term
Lipid Rescue from Local toxicity resulting in cardiac arrest
1. Bolus
2. Infusion rate
3. What to do if not working |
|
Definition
1. 1.5 mL/kg
2. 0.25 mL/kg/min or 15 mL/hr
3. Repeat bolus or double infusion |
|
|
Term
1. Nerve block use
2. Epidural is a combo of what usually |
|
Definition
1. Post surgical pain or rib fracture
2. Fentanyl and opioid |
|
|
Term
Assessment of pain
1. 3 unidimensional
2. 2 Behavioral |
|
Definition
1. Verbal rating scale; Numerical rating scale; Visual analogue scale
2. Behavior pain scale; Critical care pain observation tool |
|
|
Term
Assessment of Sedation
1. 2 Subjective
2. 4 Objective |
|
Definition
1. Ramsey scale; Riker Sedation-Agitation Scale
2. Heart rate variability; Lower-esophageal contractility; EEG; Bispectral index (BIS)
Usually use one from each category
|
|
|
Term
Behavioral Pain Scale
1. Numbers and trends
2. 3 Categories measured |
|
Definition
1. 1-4 with 1 = less and 4 = most
2. Facial expression; Upper limb; Compliance with ventilation |
|
|
Term
Ramsey Scale
1. what is scale
2. What is awake
3. What is asleep |
|
Definition
|
|
Term
Riker Sedation-Agitation Scale
1. Scale
2. Low, High |
|
Definition
1. 1-7
2. Low = 1: narousable
High = 1: dangerous agitation |
|
|
Term
3 Routes of Administration for Analgesics |
|
Definition
1. IV push (creates burden on nursing)
2. Continuous infusion (may overmedicate)
3. PCA (pt must be able to perform) |
|
|
Term
Fentanyl
1. How much more potent than morphine
2. Onset and duration
3. Bad point |
|
Definition
1. 75-100
2. Rapid and short
3. Active metabolite |
|
|
Term
Morphine
1. Lipid solubility
2. Causes realease of what signaling molecule
3. Duration |
|
Definition
1. Least lipid soluble
2. Histamine
3. 4-12 hours |
|
|
Term
Hydromophone
1. Potency compared with morphine
2. Duration
3. Active metabolites? |
|
Definition
|
|
Term
5 Nonopioid classes/drugs |
|
Definition
1. Locals
2. APAP
3. COX inhibitors
4. Antiepileptics
5. Ketamine |
|
|
Term
|
Definition
1. Propofol
2. Alpha-agonist
3. Neuroleptics
4. Benzos
5. Other |
|
|
Term
Propofol
1. MOA
2. Analgesia? Amnesia?
3. Duration
4. What is PRIS?
5. Need to monitor what? |
|
Definition
1. Enhances GABA and antagonist at NMDA
2. Little analgesic, but some antegrade amnesia
3. Ultra-short acting
4. Propofol Related Infusion Syndrome (PRIS): Metabolic acidosis, rhabdo, elevated CK, renal failure, myocardial failure, arrhythmias, hyperlipidemia...most likely with prolonged infusion at high dose
5. TGs...Change tubing every 12 h...1.1 kcal/mL |
|
|
Term
Dexmedetomidine
1. Good point
2. Labeled for how much use?
3. S/E
4. Duration of action |
|
Definition
1. Easy arousability
2. < 24 hours
3. Hypotension and brady
4. 2-6 hours |
|
|
Term
Benzodiazepines
1. What type of amnesia
2. ____ sparing effect b/c of dec anticipatory effects |
|
Definition
|
|
Term
Midazolam
1. Half-life
2. Duration |
|
Definition
1. Very short
2. 2-6 hours |
|
|
Term
Lorazepam
1. Potency of BZDs
2. Active metabolite?
3. Solvent |
|
Definition
1. Most potent
2. None
3. Propylene glycol so as low as 1 mg/kg can cause toxicity |
|
|
Term
Diazepam
1. Duration
2. How often is it used |
|
Definition
|
|
Term
|
Definition
1. Neuroleptics
2. Etomidate (procedural)
3. Ketamine
4. Barbiturates
5. Benadryl |
|
|
Term
5 Indications for NMB use |
|
Definition
1. ALI/ARDS
2. Status asthmaticus
3. Elevated ICP
4. Tetanus
5. Therapeutic hypothermia |
|
|
Term
|
Definition
1. Decrease O2 consumption
2. Facilitates mechaincal ventilation
3. Decreases muscle spasms
4. Avoids barotrauma |
|
|
Term
Aminosteroidal Nondepolarizing NMBs (5) |
|
Definition
1. Pancuronium
2. Pipecuronium
3. Vecuronium
4. Rocuronium
5. Rapacuronium |
|
|
Term
Benzylisoquinolinium Nondepolarizing NMBs (5) |
|
Definition
1. Cisatracurium
2. Atracurium
3. D-tubocurarine
4. Doxacurium
5. Mivacurium |
|
|
Term
Succinylcholine
1. Only for what type of procedures
2. Onset/Duration
3. ADE |
|
Definition
1. Short, RSI
2. Fast onset, short duration
3. Hyperkalemia |
|
|
Term
Pancuronium
1. Class
2. Duration of action
3. ADEs (2)
4. Avoid in what (2) |
|
Definition
1. Aminosteroidal
2. Long (60-90 min)
3. Vagolytic; Histamine release
4. Renal and hepatic failure |
|
|
Term
Vecuronium
1. Class
2. Length
3. Good difference from pancuronium
4. Avoid in |
|
Definition
1. Aminosteroidal
2. Intermediate
3. Not a vagolytic
4. Avoid in renal and hepatic failure |
|
|
Term
Rocuronium
1. Class
2. Duration
3. Metabolite? |
|
Definition
1. Aminosteroidal
2. Intermediate (30 min)
3. Active metabolite |
|
|
Term
Atracurium
1. Class
2. Special elimination
3. Duration |
|
Definition
1. Benzylisoquinoliniums
2. Hoffman (avoids renal and hepatic issues)
3. Intermediate |
|
|
Term
Cisatracurium
1. Class
2. Duration
3. Advantage over atracurium
4. Elimination |
|
Definition
1. Benzylisoquinoliniums
2. Intermediate
3. Less mast cell degranulation
4. Hofmann elimination |
|
|
Term
3 monitoring parameters with NMBs |
|
Definition
1. Observation (lack of movement)
2. Ventilator software (can detect overbreathing)
3. Peripheral nerve stimulation (Train of Four [goal is 2-3]) |
|
|
Term
|
Definition
1. Analgesia
2. Sedation (as deep as possible)
3. Eye care to prevent eye drying damage |
|
|
Term
Complications of NMBs (4) |
|
Definition
1. Prolonged recovery so do not stop sedation and analgesia at same time as NMB
2. Acute quadriplegic myopathy: with long use, nutritional def, DDI
3. Myositis ossificans: Connective tissue; fibrobalsts; osteoblasts; supportive care and PT
4. Tachyphylaxis |
|
|
Term
6 Keys to Safe Storage of NMBs |
|
Definition
1. High-alert med list
2. Distinctive labeling
3. Auxillary labels
4. Avoid similar names
5. Store separately
6. Limit availability |
|
|
Term
6 steps for safe use of NMBs |
|
Definition
1. Only use as last option 2. Never "prn agitation"
3. D/C once moved to floor
4. Never call "muscle relaxants"-->Paralyzing agents
5. Use lowest dose possible
6. Focused educaiton (providers on complications & risk) |
|
|
Term
Assessing Pain goals for
1. Behavioral Pain Scale (BPS)
2. Critical Care Pain Observation (CCPO) |
|
Definition
|
|
Term
Assessing Sedation goals
1. Ramsey or Riker Sedation/Agitation Scale
|
|
Definition
1. Ramsey: 2-3
2. Riker: 3-4 |
|
|
Term
Atropine
1. Dose
2. When to use
3. When not to use |
|
Definition
1. 0.5 mg IVP up to 3 mg
2. Brady
3. Cardiac ischemia, heart transplant |
|
|
Term
Dopamine
1. Use
2. Infusion rate
3. Must maintain |
|
Definition
1. Bradycardia
2. 2-10 mcg/kg/min
3. Maintain intravascular volume |
|
|
Term
Isoproterenol
1. Start
2. Used to tx |
|
Definition
1. 2-10 mcg/kg/min
2. Brady |
|
|
Term
Adenosine
1. Dose
2. Contraindicated in
3. When can you use |
|
Definition
1. 6, 12, 12 followed by 20 mg flush fast push
2. WPW
3. Regular and monomorphic tachycardia (particularly narrow QRS)
|
|
|
Term
3 antiarrhythmics for wide QRS |
|
Definition
1. Procanamide
2. Amiodarone
3. Sotalol |
|
|
Term
Pulseless V Tach or V fib
1. Order of stuff |
|
Definition
1. Shock
2. CPR X 2 min
3. Shock
4. Epi (1 mg IVP Q3-5 min)
5. Shock
6. Amiodarone (300 mg load)
7. Shock
8. Epi
9. Amiodarone (150 mg bolus): 1 mg/min drip if converts |
|
|
Term
Vasopressin
1. Dose
2. When to use
|
|
Definition
1. 40 U IVP
2. Longer half-life version of Epi so use in a pt who responds to epi and then decompensates |
|
|
Term
Pulseless Electrical Activity/Asystole
1. Looks like what?
2. Treatment algorithm |
|
Definition
1. Sinus brady but w/o pulse
2. CPR X2 min and 1 mg epi Q3-5 min
If shockable, switch to other route |
|
|
Term
4 Reversible H's of arrest |
|
Definition
1. Hypovolemia
2. Hypoxia
3. Hydrogen ions
4. Hypo/hyperkalemia |
|
|
Term
4 reversible T's of arrest |
|
Definition
1. Tension pneumothorax
2. Tamponade
3. Toxins
4. Thrombosis |
|
|
Term
What lab can you not get with IO |
|
Definition
|
|
Term
|
Definition
1. Naloxone
2. Atropine
3. Vasopressin
4. Epi
5. Lidocaine |
|
|
Term
Diagnostic PH
1. Pulmonary arterial pressure > |
|
Definition
|
|
Term
|
Definition
1. Idiopathic
2. Heritable
3. Drugs and Toxin induced
4. Persistant HTN of newborn |
|
|
Term
|
Definition
Pulmonary veno-occlusive disease and or pulmonary capillary hemangiomatosis |
|
|
Term
|
Definition
|
|
Term
|
Definition
Lung disease/hypoxia...basically anything reducing oxygen |
|
|
Term
|
Definition
Chronic thromoboembolic pulmonary HTN |
|
|
Term
|
Definition
PH with unclear or multifactorial mechaisms |
|
|
Term
Measure labs how often for PH |
|
Definition
Clinical assessment, WHO-FC, ECG, 6 min walk test, BNP at baseline and then every 3-6 months |
|
|
Term
|
Definition
1. Exercise
2. Support group
3. Don't get prego
4. Travel may need O2
5. Psychosocial support
6. Influenza adn pneumovax |
|
|
Term
Supportive therapy PAH (4) |
|
Definition
1. Oral anticoagulants
2. Diuretics
3. Oxygen
4. Digoxin |
|
|
Term
Epoprostenol
1. How long stable
2. Initial/Optimal dose
3. What hapens if suddenly stopped |
|
Definition
1. 8-12 hrs at room temp, must give by continious infusion pump
2. 2-4 ng/kg/min; 20-40 ng/kg/min
3. Rebound PH and death
*$33,153 |
|
|
Term
Iloprost
1. Dosing route (2)
2. Dose schedule
|
|
Definition
1. Aerosol, intravenous
2. 2.5-5 mcg/inhalation 6-9 times daily
*$92,146 |
|
|
Term
Treprostinil
1. Stable how long
2. Routes (4)
3. Dose
|
|
Definition
1. 48 hrs room temp
2. SC (preferred), IV, Inhaled, oral
3. 1-2 ng/kg/min; Optimal 20-80 ng/kg/min
$97.615 |
|
|
Term
|
Definition
HA, jaw pain, flushing, nausea, diarrhea, skin rash, musculoskeletal pain |
|
|
Term
Bosentan
1. Class
2. Dose
3. Monitoring
4. Decreases efficacy of what |
|
Definition
1. Entothelin receptor antagonists
2. 62.5 mg BID for 4 wks, then increase to 125 mg BID
3. LFTs monthly and HCt Q3 months
4. Oral contraceptives
*$55,890 |
|
|
Term
Ambrisentan
1. Category
2. Dose
3. Monitoring
4. Decreases efficacy of |
|
Definition
1. Endothelin receptor antagonists
2. 5 mg daily, if tolerated inc 10 mg daily
3. LFTs monthly, Hct Q3M
4. OC
*$56,736 |
|
|
Term
PDE inhibitor approved for PH |
|
Definition
Sildenafil
20 mg TID
*12,761 |
|
|